Addiction Psychiatry

Addiction Psych 2013

Our one-year addiction psychiatry-training program is fully accredited by the Accreditation Council for Graduate Medical Education (ACGME). The program is open to physicians who have completed a four-year psychiatry residency program and are eligible for licensure in the state of Kansas. Preference is given to those with demonstrated interest in addiction and with intent to practice addiction psychiatry upon completion of the program. Interest in addiction research is desirable but not required. This program primarily provides a clinical training experience with a diverse patient population diagnosed and treated in multiple settings including the inpatient, outpatient, consultation, and residential services of a university hospital, Veterans Affairs medical center, and community mental health center.

Program Objectives

  • Provide specialized training for psychiatrists in treating addiction disorders
  • Enhance training resources available to clinicians in the metropolitan area
  • Serve as a resource for clinical addiction research
  • Facilitate transfer of specialized addiction treatment approaches to community agencies

The addiction resident provides direct patient care for patients in residential care, outpatient intensive treatment, and inpatient detox and consultation. Treatment modalities used are as follows:

  • Individual and Group Therapies
  • Motivational Approaches
  • Relapse Prevention Methods
  • Cognitive Behavioral Psychotherapy
  • Psychoeducational Programming
  • Psychopharmacologic Management of Detox, Craving, Relapse Prevention
  • Comorbidity Diagnosis and Treatment Strategies

Training Sites

The training sites are the University of Kansas Medical Center, the Kansas City Veterans Affairs Medical Center and Johnson County Mental Health Center-Adolescent Center for Treatment. An outline of the training experiences follows:

1 Month
1 Month
10 Months

 

Johnson County Mental Health-Adolescent Center for Treatment
50%

KU Medical Center
Pain Management
40%

KU Medical Center
Methadone Clinic
Suboxone Clinic
10%

 

Johnson County Mental Health-Adolescent Center for Treatment
50%

KU Medical Center
OB/Addiction Research
40%

KU Medical Center
Methadone Clinic
Suboxone Clinic
10%

 

KCVAMC
Adult Residential/Partial
Hospitalization Treatment
90 %

KU Medical Center
Methadone Clinic
Suboxone Clinic
10%

 

Didactic Curriculum

Neurobiology of Drug Abuse

  • Animal Models of Drug Dependence
  • Behavioral Models of Drug Dependence
  • Animal Models of Relapse Liability
  • Brain Reward Circuitry
  • Genetic Contributions to Drug Dependence
  • Epidemiology of Addictive Disorders

Overview of Addiction Treatment

  • Historical Perspectives of Drug Intoxication and Abuse
  • Use of Various Substances in Cultural and Religious Settings
  • Evolution of Social and Governmental Theory and Controls of Drug Usage
  • Screening, Diagnosis and Assessment
  • Laboratory in Diagnostic Assessments
  • Brief Interventions

Addiction Treatment

  • Detoxification
    • Alcohol, Benzodiazepines, Barbituates
    • Cocaine
    • Methamphetamine
    • MDMA
    • Heroin, Prescription Opiates
    • Ultra Rapid Opiate Detox
    • Hallucinogens, PCP, GHB, Inhalants
    • Marijuana
  • Complicated Detox Strategies
    • Polydrug and Alcohol Combinations
    • Acute Psychosis and Drug Abuse
    • Overdose Emergency Management
  • Components of Successful Addiction Treatment
  • Choice of Setting, Duration and Intensity of Treatment
  • Ethical Issues in Addiction Treatment
  • Harm Reduction
  • Drug Courts and Role of Law Enforcement
  • Complementary and Alternative Therapies
  • Special Population Approaches: Genderal, Ethnic, Sexual Preference, Age, HIV
  • Addiction in the Primary Care Setting
  • Addiction Treatment in Incarcerated Populations

Behavioral Approaches to Addiction Treatment

  • Motivational Approaches
  • Cognitive-Behavioral Treatment
  • Relapse Prevention
  • Network Therapy
  • Individual Psychotherapy
  • Group Therapy
  • Family/Couples Approaches to Treatment Engagement
  • Contingency Management
  • Community Support Groups, Twelve-Step Programs, Faith-Based Approaches
  • Therapeutic Community

Drug Abuse and Psychiatric Co-Morbidity

  • Substanee-Induced Psychiatric Disorders
  • Diagnostic Strategies for Comorbid Psychiatric Disorders
  • Comorabid Affective Disorders
  • Comorbid Anxiety Disorders, PTSD, OCD
  • Comorbid Schizophrenia, Schizoaffective and Other Psychotic Disorders
  • Aomorbid ADHD, ADD
  • Comorbid Eating Disorders and Pathological Gambling
  • Comorbid Impulse Disorders
  • Comorbid Personality Disorders: Borderline, Antisocial Personality
  • Psychopharmacology for Addiction and Comorbid Disorders
  • Harm Reduction in Clinical Practice
  • Controlled Drinking, Abstinence Goals and Other Controversies

Psychopharmacology in Addiction

  • Characteristics of Addicting Drugs
  • Determining Risk of Addiction; Post-Release Monitoring
  • Pharmocokinetic and Pharmacodynamic Principles
  • Pharmacology of Alcohol
  • Pharmacology of Benzodiazepines and Other Sedative-Hypnotics
  • Pharmacology of Opiates
  • Pharmacology of Cocaine, Methamphetamine and Amphetamines, MDMA
  • Pharmacology of GHB, PCP, Ketamine, and NMDA Antagonists
  • Pharmacology of Nicotine and Various Smoking Products
  • Pharmacology of Marijuana
  • Pharmacology of Hallucinogens and Designer Drugs
  • Pharmacology of Inhalants
  • Using Medications for People with Addictive Disorders
  • Evidence-Based Psychopharmacology for Addictions
  • Medications Approved for Alcohol Abuse and Dependence
  • Medication Trials for Off-Label Treatment of Addictive Disorders
  • Opiate Replacement Treatments
  • Office-Based Opiate Treatment

Medical Disorders and Complications of Addiction

  • Overview of Medical Risks Associated with Drug and Alcohol Abuse
  • Communicable Disease Risk and Monitoring
  • Cardiovascular Complications of Drug and Alcohol Abuse
  • Respiratory Tract Disorders Associated with Drug and Alcohol Abuse
  • Liver and Gastrointestinal Disorders Associated with Drug and Alcohol Abuse
  • Renal and Metabolic Disorders of Addiction
  • Neurologic and Sleep Disorders Associated with Drug and Alcohol Abuse
  • Infectious Diseases
  • Endocrine, Reproductive and Immunologic Disorders
  • Fetal Alcohol Syndrome
  • Perinatal Addiction

Pain and Addiction Disorders

  • Neurophysiology of Acute and Chronic Pain
  • Principles of Pain Management: the Warn on Pain
  • Psychological Approaches to Pain Management
  • Non-Opioid Medications, the WHO ladder, Adjuvant Strategy
  • Opioid Medications for Pain Management in Addicted Patients
    • Strategies for Medication Management
    • Legal Constraints and Diversion Issues
  • Use of Body Fluid Monitoring for Chronic Pain Patients
  • Practical Problems in Management of Pain
  • Prescription Opoid Abuse in the Chronic Pain Patient

Children and Adolescents

  • Adolescent Risk and Protective Factors
  • Binge Drinking Among College Students
  • Tobacco Use by Youth
  • Screening for Alcohol, Tobacco and Drug Use in Adolescents
  • Screening Questionnaires for Young Men and Women
  • Office Assessment of the Substance-Using Adolescent
  • Adolescent Treatment and Relapse Prevention
  • Confidentiality and the Family
  • Co-Occurring Disorders in Adolescents
    • Bipolar Disorder
    • ADHD
    • Psychopharmacology for the Adolescent: Risks and Benefits

The Evaluation Process

Regular verbal feedback is an integral part of the training experience. Formal online evaluations are completed by the responsible supervising attendings, nurses and social workers at the conclusion of each rotation or on a quarterly basis.

Residents meet with the residency program director twice each year to review his/her progress and to assess the trainee’s caseload, and discuss any of the resident’s concerns.

 

Addiction Psychiatry Training Program

913-588-6412
Program Director -  Jan L. Campbell, M.D.
Associate Program Director - Amad U. Din, M.D.
Residency Coordinator - Stacy E. Buckley
sbuckley2@kumc.edu

 

Related Links

Last modified: Feb 14, 2014
ID=x8394